Article

FDA Clears Technology Platform for Examining Cardiac Tissue

Author(s):

The mapping system incorporate referencing based on 3D navigation, similar to what is used for brain, spine, ENT, and lung surgeries.

The US Food and Drug Administration (FDA) has granted market clearance to CardioNXT for new platform technology for the examination of problematic cardiac tissue causing arrhythmias and directing the delivery of instruments to target tissue with precision and accuracy.

The Platform

The platform is set to include the iMap 3D Navigation & Mapping System, Activate Software, Sensor Enabled Axis Patient Patches, and MultiLink Sensor Enabled Catheter.

The iMap System can incorporate “dynamic referencing” based on 3D Navigation in cardiac procedures, similar to how the technology has been used for brain, spine, ENT, and lung surgeries.

The Benefit

The system achieves cardiac dynamic referencing through a patented combination of dual tracking modalities, electromagnetic, and impedance, which utilizes the MultiLink Catheter, a dual sensor enabled internal reference catheter.

"I have used products from and advised many mapping system companies,” Vivek Reddy, MD, Director of Cardiac Arrhythmia Service at Mount Sinai Hospital, said in a statement. “My advice to all is that there must be a tight integration between complex mapping and accurate navigation in order for any map of the heart to be useful in the treatment of patients, especially complex cases such as persistent AFib.

“CardioNXT has taken my advice to heart. I'm excited to see the improvements that can be made in the treatment of AFib patients with this technology,” he added. “Treatment paradigms beyond PVI are still to be determined and we need systems like this one to help us evolve treatment strategies.”

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.